Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 3 (2006), Issue 9 (September)

1. Prospective comparison of patient experience with colon imaging tests.
   Am J Med, 119(9): 791-9. [Abstract] [Full-text]
2. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
   Lancet Oncol, 7(9): 719-27. [Abstract] [Full-text]
3. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET.
   Expert Opin Drug Deliv, 3(5): 685-92. [Abstract] [Full-text]
4. Dose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism.
   Expert Opin Drug Deliv, 3(5): 677-83. [Abstract] [Full-text]
5. Proprietary Rel-Ease drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules.
   Expert Opin Drug Deliv, 3(5): 663-75. [Abstract] [Full-text]
6. Growth factor delivery for oral and periodontal tissue engineering.
   Expert Opin Drug Deliv, 3(5): 647-62. [Abstract] [Full-text]
7. Linear cyclodextrin-containing polymers and their use as delivery agents.
   Expert Opin Drug Deliv, 3(5): 641-6. [Abstract] [Full-text]
8. Pharmaceutical nanotechnology: polymeric vesicles for drug and gene delivery.
   Expert Opin Drug Deliv, 3(5): 629-40. [Abstract] [Full-text]
9. Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.
   Expert Opin Drug Deliv, 3(5): 613-28. [Abstract] [Full-text]
10. Time-controlled oral delivery systems for colon targeting.
    Expert Opin Drug Deliv, 3(5): 583-97. [Abstract] [Full-text]
11. pH-responsive shielding of non-viral gene vectors.
    Expert Opin Drug Deliv, 3(5): 563-71. [Abstract] [Full-text]
12. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Bone Marrow Transplant, 38(6): 417-20. [Abstract] [Full-text]
13. A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization.
    Bone Marrow Transplant, 38(6): 407-12. [Abstract] [Full-text]
14. Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens.
    Bone Marrow Transplant, 38(6): 413-6. [Abstract] [Full-text]
15. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    J Neurol Sci, 247(2): 121-9. [Abstract] [Full-text]
16. Is bowel preparation required before cystoplasty in children?
    J Urol, 176(4): 1574-6; discussion 1576-7. [Abstract] [Full-text]
17. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
    Cancer Chemother Pharmacol, 58(6): 742-8. [Abstract] [Full-text]
18. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
    Cancer Chemother Pharmacol, 58(6): 735-41. [Abstract] [Full-text]
19. Panmucositis and chemosensitisation associated with betel quid chewing during dose-dense adjuvant breast cancer chemotherapy.
    Cancer Chemother Pharmacol, 58(6): 835-7. [Abstract] [Full-text]
20. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.
    Cancer Chemother Pharmacol, 58(6): 794-801. [Abstract] [Full-text]
21. Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: a pilot study.
    Oncol Nurs Forum, 33(5): 1015-21. [Abstract] [Full-text]
22. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Laryngoscope, 116(9): 1651-6. [Abstract] [Full-text]
23. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
    N Engl J Med, 355(10): 983-91. [Abstract] [Full-text]
24. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy--a porcine model.
    Br J Anaesth, 97(4): 460-7. [Abstract] [Full-text]
25. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial.
    BMJ, 333(7567): 522. [Abstract] [Full-text]
26. Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement.
    J Clin Endocrinol Metab, 91(9): 3389-93. [Abstract] [Full-text]
27. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
    J Clin Oncol, 24(26): 4236-44. [Abstract] [Full-text]
28. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    J Clin Oncol, 24(26): 4333-9. [Abstract] [Full-text]
29. Evidence of innervation in talc-induced pleural adhesions.
    Chest, 130(3): 702-9. [Abstract] [Full-text]
30. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women.
    Neurogastroenterol Motil, 18(10): 911-8. [Abstract] [Full-text]
31. Induction of remission of relapsed acute myeloid leukemia after unrelated donor cord blood transplantation by concomitant low-dose cytarabine and calcitriol in adults.
    Eur J Haematol, 77(4): 345-8. [Abstract] [Full-text]
32. Prognostic factor analysis and proposed prognostic model for conventional treatment of high-grade primary gastric lymphoma.
    Eur J Haematol, 77(4): 304-8. [Abstract] [Full-text]
33. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
    Eur J Haematol, 77(4): 293-9. [Abstract] [Full-text]
34. Chemotherapy with preoperative radiotherapy in rectal cancer.
    N Engl J Med, 355(11): 1114-23. [Abstract] [Full-text]
35. Bioinformatics-assisted anti-HIV therapy.
    Nat Rev Microbiol, 4(10): 790-7. [Abstract] [Full-text]
36. Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome.
    J Surg Oncol, 94(5): 375-9. [Abstract] [Full-text]
37. Predictors of early death in a cohort of Ethiopian patients treated with HAART.
    BMC Infect Dis, 6: 136. [Abstract] [Full-text]
38. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
    J Am Coll Cardiol, 48(6): 1139-45. [Abstract] [Full-text]
39. Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.
    Biochem Biophys Res Commun, 349(2): 549-55. [Abstract] [Full-text]
40. Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.
    BJU Int, 98(4): 756-62. [Abstract] [Full-text]
41. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    J Clin Oncol, 24(27): 4499-506. [Abstract] [Full-text]
42. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry.
    J Clin Oncol, 24(27): 4492-8. [Abstract] [Full-text]
43. Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
    J Clin Oncol, 24(27): 4441-7. [Abstract] [Full-text]
44. Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.
    J Clin Oncol, 24(27): 4412-7. [Abstract] [Full-text]
45. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    J Clin Oncol, 24(27): 4397-404. [Abstract] [Full-text]
46. Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
    J Clin Oncol, 24(27): 4384-90. [Abstract] [Full-text]
47. Cerebral response to norepinephrine compared with fluid resuscitation in ovine traumatic brain injury and systemic inflammation.
    Crit Care Med, 34(10): 2651-7. [Abstract] [Full-text]
48. Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response.
    J Invest Dermatol, 126(10): 2296-301. [Abstract] [Full-text]
49. Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents.
    Biochem Pharmacol, 72(8): 941-8. [Abstract] [Full-text]
50. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
    J Natl Cancer Inst, 98(18): 1311-20. [Abstract] [Full-text]
51. Single-session prolonged alcohol-retention sclerotherapy for large hepatic cysts.
    AJR Am J Roentgenol, 187(4): 940-3. [Abstract] [Full-text]
52. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
    Clin J Pain, 22(8): 667-76. [Abstract] [Full-text]
53. Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.
    Blood, 108(7): 2332-8. [Abstract] [Full-text]
54. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study.
    Blood, 108(7): 2165-72. [Abstract] [Full-text]
55. Hypotonic versus isotonic saline in hospitalised children: a systematic review.
    Arch Dis Child, 91(10): 828-35. [Abstract] [Full-text]
56. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.
    J Infect Dis, 194(8): 1108-14. [Abstract] [Full-text]
57. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.
    J Infect Dis, 194(8): 1098-107. [Abstract] [Full-text]
58. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.
    J Infect Dis, 194(8): 1089-97. [Abstract] [Full-text]
59. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients.
    Am J Kidney Dis, 48(4): 645-51. [Abstract] [Full-text]
60. Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes.
    Am Heart J, 152(4): 676-83. [Abstract] [Full-text]
61. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Am Heart J, 152(4): 627-35. [Abstract] [Full-text]
62. Reduced pretreatment ipsilateral middle cerebral artery cerebral blood flow is predictive of symptomatic hemorrhage post-intra-arterial thrombolysis in patients with middle cerebral artery occlusion.
    Stroke, 37(10): 2526-30. [Abstract] [Full-text]
63. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke.
    Stroke, 37(10): 2463-6. [Abstract] [Full-text]
64. Physician communication when prescribing new medications.
    Arch Intern Med, 166(17): 1855-62. [Abstract] [Full-text]
65. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.
    Arch Intern Med, 166(17): 1829-35. [Abstract] [Full-text]
66. An anesthesia information system designed to provide physician-specific feedback improves timely administration of prophylactic antibiotics.
    Anesth Analg, 103(4): 908-12. [Abstract] [Full-text]
67. Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus.
    J Thorac Cardiovasc Surg, 132(4): 861-6. [Abstract] [Full-text]
68. Delivery from episcleral exoplants.
    Invest Ophthalmol Vis Sci, 47(10): 4532-9. [Abstract] [Full-text]
69. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Transl Res, 148(4): 164-70. [Abstract] [Full-text]
70. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?
    BMC Nephrol, 7: 13. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.